LBA105 Results from SunRISe-1 in patients (Pts) with bacillus Calmette–Guérin (BCG)-unresponsive high-risk non–muscle-invasive bladder cancer (HR NMIBC) receiving TAR-200 monotherapy

• DOI: 10.1016/j.annonc.2023.10.111
• Publication Date: 2023-10-20T13:23:42Z
• Authors: A. Necchi; J.M. Jacob; S. Daneshmand; G. Simone; E. Xylinas; D. Morris; P. Spiegelhalder; D. Zainfeld; T.W. Kang; J.T. Matulay; L. Belkoff; K. Decaestecker; H. Arentsen; S. Hampras; C. Cutie; H. Sweiti; K. Stromberg; J. Martin; A. Shukla; M.S. van der Heijden